Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment

March 19, 2024 updated by: AO Innovation Translation Center

Evaluation of a Growth Guiding Construct vs. Standard Dual Growing Rods and VEPTR for the Treatment of Early Onset Scoliosis Patients: A Prospective Multi-center Cohort Study With a Matched Historical Control

The foremost challenge when managing early onset scoliosis (curve deformity before the age of 10) is to prevent curve progression while maintaining growth of the spine. Current treatment options require repetitive interventions as the spine and the child grow. This study will compare two techniques of growth modulation: Standard dual growing rods versus the new Luqué Trolley screws

Hypothesis: Patients treated with the DePuy Synthes TROLLEY system will undergo fewer re-operations after 3 years of follow-up (FU) than patients included in the comparison group

Study Overview

Detailed Description

The purpose of this clinical study is to show that the growth guiding construct with DePuy Synthes TROLLEY Gliding Vehicles allows for less re-operations and for ongoing spinal growth across an instrumented immature spine while preventing curve progression in early onset scoliosis patients.

Study Type

Observational

Enrollment (Actual)

18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Genève, Switzerland
        • Hôpitaux universitaires de Genève
      • Nottingham, United Kingdom
        • Queen's Medical Centre
      • Sheffield, United Kingdom, S10 2TH
        • Sheffield Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 10 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

One third of the patients will be recruited in designated investigation sites using the TROLLEY system. For each trolley patient one to two comparative matched pairs will be generated from mining the database of the Chest Wall and Spine Deformity Study Group (CWSDSG) and the Growing Spine Study Group (GSSG).

Description

Inclusion Criteria:

  • Age 5 - 10 years
  • Diagnosis of Early Onset Scoliosis with any of the following etiologies:

Idiopathic Congenital Neuromuscular Syndromic Mesenchymal

- Significant growth potential defined by any of the following: pre peek growth velocity bone age < 10; open triradiate cartilage

  • An expected significant spinal deformity of more than 80 degrees at skeletal maturity
  • Signed informed consent as legally required (patient, parents, etc.)
  • Willingness and ability of the patient to participate in the clinical investigation including imaging and FU procedures
  • Willingness and ability of the parents to support the patient in his/her study participation
  • Ability of the patient and parents to understand the content of the patient information / informed consent form and participate in the clinical investigation
  • Signed informed consent by patient / parent(s)

Exclusion Criteria:

  • Curve magnitude and rigidity: Cobb greater than 100 degrees or bends less than 50 degrees
  • Prior spinal surgery
  • Skeletal maturity
  • Any not medically managed severe systemic disease
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spine based dual growing rod or VEPTR
Patients treated with the TROLLEY system will be compared with patients from the Chest Wall and Spine Deformity Study Group (CWSDSG) and the Growing Spine Study Group (GSSG) treated with a spine based dual growing rod or the rib based Vertical Expandable Prosthetic Titanium Rib (VEPTR, Synthes North America). For each patient in the TROLLEY group a patient from each of the databases will be selected to be matched based on diagnosis, age, gender, and spine deformity classification.
spine based dual growing rod or the rib based Vertical Expandable Prosthetic Titanium Rib (VEPTR, Synthes North America)
TROLLEY system
Growth guiding construct using the DePuy Synthes TROLLEY Gliding Vehicles (GVs). The TROLLEY system is CE marked at the time of the study conduct.
Growth guiding construct using the DePuy Synthes TROLLEY Gliding Vehicles (GVs)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of re-operations
Time Frame: 3 years FU
Number of re-operations of the spine per patient in both groups after 3 years of FU
3 years FU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sitting height
Time Frame: 10 years
10 years
Standing height
Time Frame: 10 years
10 years
Radiographic measurements
Time Frame: 10 years
  • Spine length: upper T1 to lower L5 end plates
  • Chest length: upper T1 to Lower T12
  • Instrumented spine length
10 years
Curve / deformity type characteristics
Time Frame: 10 years
  • Lenke classification
  • New EOS classification
10 years
Adverse Events related to the procedure and/or device under investigation
Time Frame: 10 years
10 years
Quality of life
Time Frame: 10 years
  • EOS Questionnaire (EOSQ 24)
  • Pediatric version of EQ-5D (EQ-5D-Y)
10 years
Pulmonary function:
Time Frame: 10 years
  • Forced vital capacity (FVC), actual [L] and predicted [%]
  • Forced expiratory volume in 1 second (FEV1), actual [L] and predicted [%]
  • Total lung capacity (TLC), actual [L] and predicted [%]
  • Use and rate of assisted ventilation
  • Residual volume (RV)
10 years
Growth potential
Time Frame: 10 years
  • Chronological age
  • Bone age (based on radiograph of the hand)
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Ouellet, MD, McGill University Health Science Centre, Montreal, Canada

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Actual)

February 1, 2023

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

August 22, 2012

First Submitted That Met QC Criteria

August 24, 2012

First Posted (Estimated)

August 27, 2012

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

March 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Onset Scoliosis

3
Subscribe